Each year, tuberculosis strikes about nine million people worldwide; about two million die from the persistent infection. The disease is becoming deadlier as more strains of the TB bacterium develop resistance to the drugs used to treat it. And the only vaccine against TB, derived from the TB bacteria that infect cows, is often ineffective: in recent tests, the vaccine protected fewer than half of those immunized.
Immunologist William Jacobs and his coworkers at New York’s Albert Einstein College of Medicine may have found a way to fortify our crumbling defenses against TB. Jacobs has created a vaccine based on the TB bacterium that infects humans; by using mutant strains of the bacterium, he has made a vaccine that he describes as safe yet far more effective than ones based on the cow TB bacteria. Jacobs hopes to have the vaccine in clinical trials within a year.
These materials were meant to revolutionize the solar industry. Why hasn’t it happened?
Perovskites are promising, but real-world conditions have held them back.
Why China is still obsessed with disinfecting everything
Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.
Anti-aging drugs are being tested as a way to treat covid
Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.
A quick guide to the most important AI law you’ve never heard of
The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.